Medicare has postponed its five-year BALANCE pilot program, aimed at expanding access to GLP-1 weight-loss drugs for seniors, after failing to secure enough insurer participation. In its place, a ...
Medicare has delayed its BALANCE program for weight-loss drugs like Wegovy. Discover the new 'bridge program' that will offer ...